Related Experiment Video
Updated: Jan 10, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Cardiovascular Disease in Pregnancy: When Two Hearts Beat as One
Chiara Tognola1, Filippo Brucato2, Alessandro Maloberti1,2
1Clinical Cardiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.
Insights
Cardiovascular disease in pregnancy poses significant risks. This review synthesizes evidence on managing cardiomyopathies, anticoagulation, and hypertension, emphasizing multidisciplinary care for improved maternal outcomes.
Area of Science:
- Cardiology and Obstetrics
- Maternal-Fetal Medicine
- Cardiovascular Health in Pregnancy
Background:
- Cardiovascular disease (CVD) is a leading cause of maternal morbidity and mortality globally.
- Physiological changes during pregnancy can exacerbate existing CVD or reveal subclinical conditions.
- Pregnancy acts as a natural cardiovascular stress test.
Purpose of the Study:
- To critically review current evidence and guidelines for managing pregnancy-related cardiovascular disorders.
- To focus on pathophysiological mechanisms, diagnostic challenges, and therapeutic controversies.
- To analyze contemporary management strategies for high-impact clinical domains.
Main Methods:
- Comprehensive review of contemporary evidence and international guidelines.
- Focused discussion on peripartum/preexisting cardiomyopathies, anticoagulation in mechanical prosthetic valves, and hypertensive disorders of pregnancy.
- Comparative analysis of European Society of Cardiology (ESC) 2025 and American Heart Association (AHA) 2020 recommendations.
Main Results:
- Shared pathophysiological mechanisms include endothelial dysfunction, angiogenic imbalance, and systemic inflammation.
- Broad consensus exists between ESC and AHA guidelines, with some discrepancies in anticoagulation targets and postpartum surveillance.
- Recent trials (CHAP, WILL) offer new insights into hypertensive disorders and long-term prevention.
Conclusions:
- Multidisciplinary care via Pregnancy Heart Teams is crucial for integrating obstetric and cardiologic expertise.
- Structured postpartum follow-up pathways are essential for improving outcomes in women with pregnancy-related cardiovascular conditions.
- Addressing shared mechanisms and guideline discrepancies can enhance maternal cardiovascular health.
Abstract:
Background: Cardiovascular disease (CVD) in pregnancy is a major cause of maternal morbidity and mortality, accounting for nearly one-third of pregnancy-related deaths worldwide. Physiological adaptations-expanded plasma volume, increased cardiac output, and a prothrombotic state-represent a natural cardiovascular stress test that may precipitate decompensation or unmask subclinical disease. Aim: This review critically examines contemporary evidence and international guidelines on the management of pregnancy-related cardiovascular disorders, focusing on pathophysiological mechanisms, diagnostic challenges, and therapeutic controversies. Content: The discussion centers on three high-impact clinical domains: (1) peripartum and preexisting cardiomyopathies, emphasizing mechanisms, prognosis, and the role of bromocriptine; (2) anticoagulation management in women with mechanical prosthetic valves, balancing maternal safety and fetal protection; and (3) hypertensive disorders of pregnancy, highlighting recent evidence from the CHAP and WILL trials and their implications for long-term cardiovascular prevention. Comparative analysis of ESC 2025 and AHA 2020 recommendations reveals broad consensus but persistent discrepancies in anticoagulation targets, postpartum surveillance, and follow-up strategies. Perspectives: Endothelial dysfunction, angiogenic imbalance, and systemic inflammation emerge as shared mechanisms linking diverse pregnancy-related cardiovascular conditions. Strengthening multidisciplinary care through Pregnancy Heart Teams, integrating obstetric and cardiologic expertise, and establishing structured postpartum follow-up pathways are essential to improve outcomes.
More Related Videos
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Mitral Valve Prolapse III: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

